Posts Tagged ‘Symplicity HTN-2’

RSS

March 10th, 2014

Selections from Richard Lehman’s Literature Review: March 10th

This week’s topics include cognitive function and brain structure in type 2 diabetics after intensive lowering of BP and lipid levels, the association of β-blocker therapy with risks of adverse CV events and deaths in those with ischemic heart disease undergoing noncardiac surgery, and more.


February 24th, 2014

Selections from Richard Lehman’s Literature Review: February 24th

This week’s topics include radiofrequency ablation vs. antiarrhythmic drugs as first-line treatment of paroxysmal AF, Symplicity HTN-1 and Symplicity HTN-3, and more.


December 20th, 2012

Is “Zapping the Kidneys” Miraculous?

and

Renal denervation for resistant hypertension is generating a lot of excitement. In this blog, Rick Lange and David Hillis take stock of the evidence and the efforts underway to explore the potential scope of indications for the procedure.


November 22nd, 2010

Treating Resistant Hypertension: Singe – Don’t Stent – The Renal Artery

For years, interventional cardiologists (and radiologists) have been stenting renal arterial stenoses in patients with resistant hypertension, despite evidence that doing so does not lower blood pressure.  It appears we had the right organ (the kidney), but we’ve been doing the wrong procedure. We should have been delivering a singe, not a stent. Advances in endovascular catheter technology […]